BioSpace News Archive

Today, the U.S. Food and Drug Administration announced a proposed rule regarding laboratory developed tests, or LDTs, which play an important role in healthcare.

Sharps Technology, Inc. announced the closing of its previously announced registered direct offering and concurrent private placement with institutional investors.

Bausch + Lomb Corporation announced it has completed its acquisition of XIIDRA 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease focusing on inflammation associated with dry eye, and certain other ophthalmology assets.

Bausch + Lomb Corporation (“Bausch + Lomb”) (NYSE/TSX:BLCO) today announced it has completed its acquisition of XIIDRA® (lifitegrast ophthalmic solution) 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease focusing on inflammation associated with dry eye, and certain other ophthalmology assets.

September 28, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the company recently entered into a third amendment to its February 2021

The U.S. Food and Drug Administration is taking steps to help further accelerate the development of novel drug and biological products for rare diseases.

Humonix Biosciences, Inc., has developed a new 3D human tissue model, called the retinal vascular dysfunction model.

AB Science wants to focus the majority of our clinical resources on the development of rare diseases with masitinib, on the development of the microtubule platform with AB8939 and future molecules of the same family due to the very encouraging first results.

GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today provided updates and guidance on its clinical development program for GH001, its proprietary inhalable mebufotenin (5-MeO-DMT) product candidate, in treatment-resistant depression (TRD).

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.